Home › Multiple Myeloma › Arizona › Goodyear
Multiple Myeloma clinical trials in Goodyear, AZ
3 studies for Multiple Myeloma are looking for participants at sites in and around Goodyear (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
RecruitingPhase 2
- City of Hope Phoenix, Goodyear
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
RecruitingPhase 3
- Research Site, Goodyear
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
RecruitingObservational studyHealthy volunteers welcome
- CTCA at Western Regional Medical Center, Goodyear
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY59 studies
- Boston, MA45 studies
- Atlanta, GA42 studies
- Houston, TX39 studies
- Durham, NC36 studies
- Nashville, TN31 studies
- Denver, CO26 studies
- St. Louis, MO26 studies
- Rochester, MN25 studies
- Columbus, OH25 studies
- Chicago, IL24 studies
- Milwaukee, WI23 studies
Other studies in Goodyear
- Non-Small Cell Lung Cancer7 studies
- Metastatic Cancer7 studies
- Breast Cancer5 studies
- Colorectal Cancer5 studies
- Lung Cancer4 studies
- Prostate Cancer4 studies
- Acute Myeloid Leukemia3 studies
- Colon Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.